Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents

Documenti analoghi

• The EU's new paediatric medicines legislation: serving children's needs?
  di: Permanand, Govin, et al.
  Pubblicazione: (2007)
• Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents()
  di: Pearson, Andrew. D.J., et al.
  Pubblicazione: (2020)
• Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents
  di: Andrew D.J. Pearson, et al.
  Pubblicazione: (2020)
• Does the EU’s Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study
  di: Lepola, Pirkko, et al.
  Pubblicazione: (2020)
• Paediatric Strategy Forum for Medicinal Product Development in Diffuse Midline Gliomas in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
  di: Andrew D.J. Pearson, et al.
  Pubblicazione: (2025)